Search Results 1061-1070 of 17593 for Assay

  1. Gastroenterology and Hepatology - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  2. A Study to Evaluate Niraparib and TSR-042 in Patients with Germline or Somatic BRCA1/2 and PALB2-related Pancreatic Cancer - Mayo Clinic

    Note: The somatic mutation could be either on a tissue-based test or the circulating tumor DNA (ctDNA)-based assay. The 6 genes that would determine ...

  3. Phase 1/2 Study Of MRTX1719 In Solid Tumors With MTAP Deletion - Mayo Clinic

    Phase 1 dose escalation only: solid tumor malignancies with homozygous deletion of the CDKN2A gene may be eligible for enrollment if the CDKN2A assay is ...

  4. Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancer - Mayo Clinic

    ER/PR determination assays performed by IHC methods according to the local institution standard protocol; Standard chemotherapy/trastuzumab declined by ...

  5. A Study to Evaluate Precision Pharmacogenomics in Cancer Patients - Mayo Clinic

    About this study. THe purpose of this study is to examine the current and (potential) future therapeutic relevance of pharmacogenomics (PGx) testing for a ...

  6. Publications - Arturo M. Valverde, M.D. - Mayo Clinic

    Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)(1). Autophagy. 2021 Jan; 17 (1):1-382 Epub 2021 Feb 08. View ...

  7. A Study of DCC-2618 vs. Sunitinib in Advanced GIST Patients after Treatment with Imatinib - Mayo Clinic

    Mutation status must be identified using a PCR or sequencing based assay. Molecular pathology report with mutation status of KIT/PDGFRA must be provided to ...

  8. Publications - Cadman L. Leggett, M.D. - Mayo Clinic

    ... Assay in Patients With Barrett Esophagus. Am J Gastroenterol. 2025 Feb 12; 120 (6):1285-1295. View PubMed; Vasireddy AR, Leggett CL, Kamboj AK. Esophageal ...

  9. A Study of an Implantable System for Remodulin Post Approval - Mayo Clinic

    Inclusion Criteria: Subject or legally authorized representative provides written authorization and/or consent per institution and geographical requirements ...

  10. Gui Piovezani Ramos, M.D. - Mayo Clinic Faculty Profiles

    ... assays for targeted monitoring of biologic therapies used to treat Crohn's disease and ulcerative colitis. Focus areas. Immune-epithelial interactions in ...